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of STEMI. Out of all the deaths, pre-procedural cardiogenic shock, cardiac arrest,
CHF, and sustained ventricular tachycardia, were present in 48%, 31%, 29%, and 7%
patients, respectively. Overall, only 42 (27%) patients died from PCI-related events,
and the majority of these were related to deﬁnite (5%) or presumed (15%) subacute
stent thrombosis. The most common cause of mortality was non-PCI-related cardiac
death (73 patients, 47%), with post-STEMI cardiogenic shock (36%) being the most
common etiology. Forty-four patients (28%) died from non-cardiac-related causes,
and anoxic encephalopathy (16%) after cardiac arrest complicating STEMI was the
most common cause in this category.
Conclusions: The majority of the deaths after PCI in a regional cardiac centre were
related to the patients’ presenting illnesses and comorbidities, rather than PCI-related
causes, which would be a better marker of PCI quality.
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Background: The MGuard Stent (MGS) was designed to prevent distal emboli-
sation of thrombus and has been shown to improve microcirculation in ST-eleva-
tion myocardial infarction (STEMI). However, there are no real world data
comparing it with the bare metal stent (BMS). The aim of this study is to deter-
mine the efﬁcacy and safety of the MGS in STEMI in the real world compared to
the BMS.
Methods: All STEMI patients undergoing primary angioplasty between July 2011
and January 2013 were included in the study except patients with cardiogenic shock
(Killip IV) or those in which the DES was implanted. In total, 262 patients were
included from a single centre, of which 35.9% had an MGS implanted. Two groups of
79 patients were established after propensity score matching (PSM), and they were
similar in terms of baseline and periprocedural variables.
Results: The mean follow-up was 321  12.94 days. There was no difference in
mortality (7.6% in both groups), major adverse cardiac events (MACE) (20.3% vs.
12.7%, P ¼ 0.198), non-cardiac mortality or non-fatal myocardial infarction (6.3%
in both groups). Target lesion revascularisation (TLR) was signiﬁcantly higher in
the MGS group (11.4% (9) vs. 1.3% (1) P < 0.01; RR 10.02 [1.23 to 81.16])
(Table 1).Table 4
Unmatched Matched
MGS
(n ¼ 92)
BMS
(n ¼ 170) P
MGS
(n ¼ 79)
BMS
(n ¼ 79) P
MACE 18.5% (17) 14.1 (24) 0.512 20.3% (16) 12.7% (10) 0.198
All-cause mortality 6.5% (6) 8.8% (15) 0.354 7.6% (6) 7.6% (6) 1
Cardiovascular
mortality and non-
fatal MI
7.6% (7) 7.1 (12) 0.870 6.3% (5) 6.3% (5) 1
Reinfarction 4.3% (4) 2.4% (4) 0.370 5.1% (4) 2.5% (2) 0.405
Heart failure 3.2% (3) 1.7% (3) 0.290 3.8% (3) 1.3% (1) 0.305
TLR 9.8%(9) 2.9% (5) 0.019 11.4% (9) 1.3% (1) 0.009
TVR 9.8%(9) 2.9% (5) 0.019 11.4% (9) 1.3% (1) 0.009
Stent thrombosis 2.2% (2) 0.6% (1) 0.250 2.4% (2) 1.3% (1) 0.560
Acute 1.1% (1) 0.0% (0) 1.3% (1) 0.0% (0)
Subacute 1.1% (1) 0.6% (1) 1.3% (1) 1.3% (1)
Peak troponin I
(ng/dL)
90.16 
82.11
115.53 
128.88
0.444 91.32 
86.08
95.75 
105.20
0.683Conclusions: Our study is the ﬁrst to compare the MGS with the BMS in STEMI in
the real world, and it also appears to conﬁrm that although the MGS is a safe device in
STEMI that is not associated with increased mortality, it is associated with a higher
long-term TLR rate.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AcTCT-43
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Background: Percutaneous coronary intervention (PCI) of the infarct related arter-
y(IRA) during primary PCI for ST elevation myocardial infarction (STEMI) is
appropriate. Two retrospective analyses suggested that, direct PCI to the IRA without
knowledge of the anatomy of the contra lateral artery is feasible .This approach would
shorten the door to balloon time which is a validated surrogate for mortality in AMI.
We have reported the feasibility of such an approach during transradial primary PCI in
a pilot study (Direct prospective study). In the present clinical study we tested the
hypothesis that in anterior STEMI, direct PCI to left anterior descending (LAD) artery
before right coronary artery angiography is feasible and this would shorten the door to
balloon (d2b) time, even in the hands of operators who have shifted from femoral to
radial approach.
Methods: Anterior wall STEMI was diagnosed by standard criteria. All consecutive
patients of anterior MI admitted between March 2012 to April 2014 were studied
prospectively. Patients with cardiogenic shock were excluded. Patients were pre-
treated with chewable aspirin 150 to 325 mg , ticagrelor 180 mg and atorvastatin 80
mg and shifted to cath lab . Radial access was obtained by anterior wall puncture of
the right radial artery. LMCA was hooked with 6F XB guiding catheter and primary
PCI to LAD was done as per standard protocol. After successful PCI to LAD, the
RCA angiogram was performedwith a 5 F TF catheter . All the intervals were
recorded.
Results: 41 patients of anterior MI were treated. 30 drug eluting stents and 12 bio-
resorbable vascular scaffolds were deployed. The median d2b time was 35+11.8
minutes and the mean d2b time was 36.46+ 14.3min. In two cases SL (2) and (8), the
RCA angiogram required multiple attempts with different catheters. Prior RCA
angiogram would have prolonged the median d2b time by 2.45 minutes (p¼0.05 sec)
and mean d2b time by 4.76 minutes (p¼< 0.05 sec).
Conclusions: From this multicenter study, we conclude that in anterior wall
STEMI, it is feasible to perform PCI to LAD directly without knowing the RCA
anatomy which signiﬁcantly shortens the d2b time. Randomized controlled trial is
warranted.TCT-44
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Background: Patients with ST elevation myocardial infarction (STEMI) who are
transferred for primary PCI from a non-PCI facility have longer reperfusion times
which may be associated with poorer clinical outcomes. The aim of this study was to
compare in hospital clinical outcomes among patients presenting directly to a PCI
facility (Non Transfer STEMI group) with those transferred from non-PCI facility for
primary PCI (Transfer STEMI group).
Methods: A retrospective analysis of patients undergoing primary PCI for acute
STEMI from July 2009 to Dec 2013 at a tertiary care PCI hospital was performed.
Patients were identiﬁed as Non Transfer STEMI (n¼501) and Transfer STEMI
(n¼507). Demographic characteristics, risk factors and in hospital clinical outcomes
were compared between the two groups.
Results: The basic demographic proﬁles and cardiovascular risk factors were very
similar between the two groups. The percentage of patients who presented with
cardiogenic shock and/or cardiac arrest in both groups was similar (12.8% vs 14.4%
respectively, p¼0.45). The goal door to balloon time (DTB) was achieved in 85%
of patients in Non-Transfer STEMI (< 90 min) group and 33% of patients in
Transfer STEMI group (< 120 min). 38% of patients in the transfer STEMI group
had DTB time between 120 to 180 minutes. Occurrence of Post PCI cardiogenic
shock, CHF and stroke was similar between the 2 groups. The all cause in hospital
mortality was similar in Non Transfer STEMI vs Transfer STEMI group (5.2% vs
5.3%, p¼0.9)ute Myocardial Infarction B13
Variable Hazard ratio [95%
CI]
P value
Age (per 10 year increase) 1.58 [1.30, 1.91] <0.0001
History of diabetes mellitus 1.82 [1.27, 2.62] 0.001
History of peripheral vascular disease 1.83 [1.09, 3.07] 0.02
History of smoking 1.50 [1.05, 2.14] 0.03
History of prior myocardial infarction 1.82 [1.21, 2.72] 0.004
Baseline creatinine clearance <60 2.03 [1.35, 3.07] 0.001
Killip class 1 (vs. 2-4) 0.41 [0.28, 0.61] <0.0001
LAD infarct artery (vs. all others) 1.75 [1.13, 2.70] 0.01
Door to balloon (or ﬁrst device) (per
hour)
1.09 [0.92, 1.29] 0.32
Final TIMI 3 ﬂow (vs. 0-2) 0.49 [0.34, 0.72] <0.0001
Any IAE 1.83 [1.04, 3.21] 0.04
Demographic features and clinical outcomes in Non transfer STEMI Vs
Transfer STEMI groups
Variable Non Transfer STEMI
(n¼501)
Transfer STEMI
(n¼507)
P value
Age 62 +/- 13 60 +/- 13 0.07
Males 75% 71% 0.17
Diabetes Mellitus 21% 21% 0.8
Mean Ejection fraction 47 +/- 11 47 +/- 10 0.9
Cardiogenic shock and/or cardiac
arrest before PCI
12.8% 14.4% 0.45
Cardiogenic shock after PCI 2.8% 4.2% 0.24
CHF after PCI 2.2% 2.4% 0.85
IABP use 7.6% 7.3% 0.8
Stroke after PCI 1.2% 0.6% 0.3
Goal DTB time achieved 85% (<90 min) 33% (<120 min) <0.001
In hospital mortality 5.2% 5.3% 0.9
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: Current systems of rapid transfer and PCI in acute STEMI patients
transferred for primary PCI from non PCI facility enable these patients to have similar
short term clinical outcomes as patients presenting directly to PCI facility.
TCT-45
Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in
Primary Percutaneous Coronary Intervention: A Meta-analysis of 26
Randomized Controlled Trials
Alok Saurav1, Ajay K. Kaja2, Vimal Kandasamy2, Manu Kaushik1, Michael DelCore1,
Aryan Mooss1, Michael D. White1, Mark Woodruff1
1Cardiac Center, Creighton University Medical Center, Omaha, NE, 2Dept. of
Internal Medicine, Creighton University Medical Center, Omaha, NE
Background: Ischemic post-conditioning (IPoC) is believed to improve the outcome
in ST elevation myocardial infarction (STEMI) undergoing primary percutaneous
intervention (PPCI) by minimizing the reperfusion injury though several trials have
shown variable results. We sought to perform a meta-analysis of randomized
controlled trials (RCTs) comparing IPoC versus standard therapy during PPCI.
Methods: PubMed, Cochrane and Web of Science databases were searched through
April 30th 2014 for RCTs comparing IPoC versus standard therapy during PPCI.
Outcomes analyzed were infract size by MRI (% of LV mass), peak cardiac bio-
markers(troponins), left ventricle ejection fraction(LVEF) by MRI & transthoracic
echo(TTE), ST segment resolution of  70% (ST70), death, myocardial infarc-
tion(MI) and subsequent revascularization. Study quality, publication bias, heteroge-
neity were assessed. Random effect model used for data analysis.
Results: 26 RCTs with 2330 patients (IPoC 1169, Control 1161) were included for the
analysis. Infarct size assessed by MRI (SMD -0.06 (p¼0.84) at 1 wk, -0.03 (p¼0.88)
at 1-6 mo), peak troponin (SMD 0.04 p¼0.91), ST70 (RR 1.04 p¼0.78) and LVEF
both by MRI (SMD 0.14 (p¼0.12) at 1wk, 0.04 (p¼0.7) at 1-6 mo) & TTE (SMD
0.28 (p¼0.1) at 1wk, 0.11 (p¼0.57) at 1-6 mo, 1.18(p¼0.06) at 1-3 yr) were similar in
both groups (IPoC versus control). Similarly there was no difference in clinical
endpoints like death (RR 1.44 p¼0.28), MI (RR 1.83 p¼0.37) and subsequent
revascularization (RR 1.2 p¼0.75).
Conclusions: IPoC compared to standard therapy is neither associated with any
signiﬁcant beneﬁt in terms of clinical outcomes nor improvement in degree of
myocardial necrosis in STEMI patients undergoing PPCI.
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Background: There is very little clinical data or speciﬁc management guidelines for
very elderly patients with ST Elevation MI (STEMI). We evaluated our practice in the
management of STEMI in patients over age 85.
Methods: A retrospective study of STEMI patients aged >85 in a PPCI (Primary
percutaneous coronary intervention) centre in the UK between April 2012-November
2013. Data was collected from Intellect, MINAP databases and discharge documents.
Results: Of the 993 patients with STEMI, 66 (6.6%) were > 85 years of age. There
were 38 males and 28 females (average age 88 (85-96) years). 35(63%) had PPCI and
31 (27%) treated medically. Inferior MI (50%) was more common than Anterior
(36%). Patients had multiple co-morbidities: Hypertension (32), smoking history (30),
Ischaemic Heart Disease (11), Hyperlipidaemia (8), Diabetes Mellitus (7) and Stroke
(6). 77% (51) were discharged alive and 23 % (11) died in hospital and a further 16%
(11) died 1 year post-discharge. In –hospital complication rate was 13 %( 8). Of 31
managed conservatively, 21 (67%) were females. Average age 89 years with multiple
co-morbidities. Presentation included dizziness, abdominal pain, feeling unwell,
vomiting and collapse. PPCI was not offered due to late presentation (>12 hours afterB14 JACC Vol 64/11/Suppl B jsymptom onset) (32%), poor prognosis, cardiogenic shock, high risk of bleeding,
resolution of symptoms and ECG and frailty. 20 (64%) were discharged alive, 7(22%)
died in the hospital and 4 transferred to a different hospital. Additional 8 (25%) died 1
year post-discharge. Complication rate was 12%. In the PPCI group (35), 24 (68%)
male patients, average age 87 years presented with typical symptoms and multiple co-
morbidities. 30(85%) of patients were discharged alive and a further (3)8.5% died
within 1 year post-discharge. Complication rate was 14%.
Conclusions: Elderly patients undergoing PPCI had better outcomes. Both groups had
multiple co-morbidities. Overall complication rate was 13%; although PPCI group had
a higher complication rate but a lower mortality 1 year post-discharge. Therefore,
PPCI has a role in treating the very elderly with STEMI, this analysis emphasises the
need for clinical trials targeted at this population.
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Background: Rapid reperfusion with primary percutaneous coronary intervention
(PCI) improves survival in patients with ST-segment elevation myocardial infarction
(STEMI). Pre-procedural cardiopulmonary instability and adverse events (IAE) may
delay reperfusion time and worsen prognosis. We set out to evaluate the relationship
between pre-procedural cardiopulmonary instability and adverse events (IAE), door-
to-balloon time (DBT), and outcomes in the HORIZONS-AMI trial.
Methods: Pre-procedural cardiopulmonary IAE included sustained ventricular or
supraventricular tachycardia or ﬁbrillation requiring cardioversion or deﬁbrillation,
heart block or bradycardia requiring pacemaker implantation, severe hypotension
requiring vasopressors or intraaortic balloon counterpulsation, respiratory failure
requiring mechanical ventilation, and cardiopulmonary resuscitation. We compared
3-year outcomes of patients with and without IAE according to DBT.
Results: Among 3,602 patients, 159 (4.4%) had at least one IAE. DBT did not differ
signiﬁcantly in patients with and without IAE; however, patients with IAE were less
likely to have TIMI 3 ﬂow after PCI. Mortality at 3 years was signiﬁcantly higher in
patients with vs. without IAE (17.0% vs. 6.3%, P< 0.0001), and IAE was an inde-
pendent predictor of mortality (see Table), whereas DBT was not. However, a sig-
niﬁcant interaction was present such that 3-year mortality was reduced in patients with
DBT < 99 minutes (the median) vs. 99 minutes to a greater extent in patients with
IAE (9.9% vs. 20.7%, HR[95%CI] ¼ 0.43 [0.16,1.16]) compared to those without
IAE (5.0% vs. 7.2%, HR ¼ 0.69 [0.50,0.95], Pinteraction¼0.004).
Conclusions: IAE prior to PCI is an independent predictor of death and identiﬁes a
high-risk group in whom faster reperfusion may be particularly important to improve
survival.TCT-48
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Background: No consensus exists about which coronary artery should be ﬁrstly
catheterized in primary PCIs. Initial catheterization of the “culprit artery” (supposed
by ECG) could reduce reperfusion time. However, knowledge of multivessel diseaseSeptember 13–17, 2014 j TCT Abstracts/Acute Myocardial Infarction
